Microfluorimetry defines early axonal damage in a rat model of optic neuritis: A novel method targeting early CNS autoimmunity

Martha E. Stokely, Manzoor Bhat, Peter Koulen

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Autoimmune optic neuritis is a common early manifestation of multiple sclerosis (MS), yet early therapeutic interventions for MS often have high ocular toxicity associated with increased risks for glaucoma, cataract, or retinopathy. This need to discover better early treatment options prompted our development of a sensitive and reliable means to quantify the broad range of pathologies that potentially develop very early in autoimmune optic neuritis. Tissue microfluorimetry was used to measure seven established markers for human MS pathology in normal and autoimmune optic nerves 13 days after antigen exposure, in a Brown Norway rat model of myelin oligodendrocyte glycoprotein (MOG) peptide (35-55)-induced autoimmune optic neuritis. Optic neuritis rats demonstrated early and significant pathologic changes in five established indices for neuroinflammation, immune infiltration, and demyelination that accurately modeled pathologies characteristic of MS. Two indices of MS-like axon damage advanced significantly within 13 days of antigen exposure. Fluorimetrically measured immunoreactivity (-ir) was significantly decreased for paranodin (PN, the requisite axonal paranodal junction protein) and significantly increased for amyloid precursor protein (APP), indicating loss of paranodal junctions and impaired fast axonal transport, respectively. Measurements showing decreased PN-ir with increased APP-ir quantitatively defined a pattern of early axonal damage in autoimmune optic neuritis.

Original languageEnglish (US)
Pages (from-to)217-228
Number of pages12
JournalJournal of Neuroscience Methods
Volume166
Issue number2
DOIs
StatePublished - Nov 30 2007
Externally publishedYes

Fingerprint

Cytophotometry
Optic Neuritis
Autoimmunity
Multiple Sclerosis
Amyloid beta-Protein Precursor
Pathology
Antigens
Axonal Transport
Demyelinating Diseases
Optic Nerve
Glaucoma
Cataract
Axons
Peptides
Proteins

Keywords

  • Autoimmune optic neuritis
  • Axon pathology
  • Experimental methods
  • Multiple sclerosis

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Microfluorimetry defines early axonal damage in a rat model of optic neuritis : A novel method targeting early CNS autoimmunity. / Stokely, Martha E.; Bhat, Manzoor; Koulen, Peter.

In: Journal of Neuroscience Methods, Vol. 166, No. 2, 30.11.2007, p. 217-228.

Research output: Contribution to journalArticle

@article{972719272a9b457caf6c679060475e50,
title = "Microfluorimetry defines early axonal damage in a rat model of optic neuritis: A novel method targeting early CNS autoimmunity",
abstract = "Autoimmune optic neuritis is a common early manifestation of multiple sclerosis (MS), yet early therapeutic interventions for MS often have high ocular toxicity associated with increased risks for glaucoma, cataract, or retinopathy. This need to discover better early treatment options prompted our development of a sensitive and reliable means to quantify the broad range of pathologies that potentially develop very early in autoimmune optic neuritis. Tissue microfluorimetry was used to measure seven established markers for human MS pathology in normal and autoimmune optic nerves 13 days after antigen exposure, in a Brown Norway rat model of myelin oligodendrocyte glycoprotein (MOG) peptide (35-55)-induced autoimmune optic neuritis. Optic neuritis rats demonstrated early and significant pathologic changes in five established indices for neuroinflammation, immune infiltration, and demyelination that accurately modeled pathologies characteristic of MS. Two indices of MS-like axon damage advanced significantly within 13 days of antigen exposure. Fluorimetrically measured immunoreactivity (-ir) was significantly decreased for paranodin (PN, the requisite axonal paranodal junction protein) and significantly increased for amyloid precursor protein (APP), indicating loss of paranodal junctions and impaired fast axonal transport, respectively. Measurements showing decreased PN-ir with increased APP-ir quantitatively defined a pattern of early axonal damage in autoimmune optic neuritis.",
keywords = "Autoimmune optic neuritis, Axon pathology, Experimental methods, Multiple sclerosis",
author = "Stokely, {Martha E.} and Manzoor Bhat and Peter Koulen",
year = "2007",
month = "11",
day = "30",
doi = "10.1016/j.jneumeth.2007.07.010",
language = "English (US)",
volume = "166",
pages = "217--228",
journal = "Journal of Neuroscience Methods",
issn = "0165-0270",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Microfluorimetry defines early axonal damage in a rat model of optic neuritis

T2 - A novel method targeting early CNS autoimmunity

AU - Stokely, Martha E.

AU - Bhat, Manzoor

AU - Koulen, Peter

PY - 2007/11/30

Y1 - 2007/11/30

N2 - Autoimmune optic neuritis is a common early manifestation of multiple sclerosis (MS), yet early therapeutic interventions for MS often have high ocular toxicity associated with increased risks for glaucoma, cataract, or retinopathy. This need to discover better early treatment options prompted our development of a sensitive and reliable means to quantify the broad range of pathologies that potentially develop very early in autoimmune optic neuritis. Tissue microfluorimetry was used to measure seven established markers for human MS pathology in normal and autoimmune optic nerves 13 days after antigen exposure, in a Brown Norway rat model of myelin oligodendrocyte glycoprotein (MOG) peptide (35-55)-induced autoimmune optic neuritis. Optic neuritis rats demonstrated early and significant pathologic changes in five established indices for neuroinflammation, immune infiltration, and demyelination that accurately modeled pathologies characteristic of MS. Two indices of MS-like axon damage advanced significantly within 13 days of antigen exposure. Fluorimetrically measured immunoreactivity (-ir) was significantly decreased for paranodin (PN, the requisite axonal paranodal junction protein) and significantly increased for amyloid precursor protein (APP), indicating loss of paranodal junctions and impaired fast axonal transport, respectively. Measurements showing decreased PN-ir with increased APP-ir quantitatively defined a pattern of early axonal damage in autoimmune optic neuritis.

AB - Autoimmune optic neuritis is a common early manifestation of multiple sclerosis (MS), yet early therapeutic interventions for MS often have high ocular toxicity associated with increased risks for glaucoma, cataract, or retinopathy. This need to discover better early treatment options prompted our development of a sensitive and reliable means to quantify the broad range of pathologies that potentially develop very early in autoimmune optic neuritis. Tissue microfluorimetry was used to measure seven established markers for human MS pathology in normal and autoimmune optic nerves 13 days after antigen exposure, in a Brown Norway rat model of myelin oligodendrocyte glycoprotein (MOG) peptide (35-55)-induced autoimmune optic neuritis. Optic neuritis rats demonstrated early and significant pathologic changes in five established indices for neuroinflammation, immune infiltration, and demyelination that accurately modeled pathologies characteristic of MS. Two indices of MS-like axon damage advanced significantly within 13 days of antigen exposure. Fluorimetrically measured immunoreactivity (-ir) was significantly decreased for paranodin (PN, the requisite axonal paranodal junction protein) and significantly increased for amyloid precursor protein (APP), indicating loss of paranodal junctions and impaired fast axonal transport, respectively. Measurements showing decreased PN-ir with increased APP-ir quantitatively defined a pattern of early axonal damage in autoimmune optic neuritis.

KW - Autoimmune optic neuritis

KW - Axon pathology

KW - Experimental methods

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=35648994881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35648994881&partnerID=8YFLogxK

U2 - 10.1016/j.jneumeth.2007.07.010

DO - 10.1016/j.jneumeth.2007.07.010

M3 - Article

C2 - 17719649

AN - SCOPUS:35648994881

VL - 166

SP - 217

EP - 228

JO - Journal of Neuroscience Methods

JF - Journal of Neuroscience Methods

SN - 0165-0270

IS - 2

ER -